Profit cap law would cost providers more than $500 million
By
Danielle Brown
Feb 03, 2022
New York’s long-term care providers could have to come up with $500 million to comply with the state’s new profit capping law — and the true number might be even higher.
Vaccine campaigns weren’t effective in increasing rates among SNF residents, staff
By
Danielle Brown
Feb 03, 2022
COVID-19 vaccination campaigns with multiple components — such as town hall meetings, educational materials and gifts — did not significantly boost uptake rates among skilled nursing staff, according...
Clinical briefs for Thursday, Feb. 3
By
Alicia Lasek
Feb 03, 2022
CMS memo: ‘Dramatic staff losses’ not happening due to vax requirements … Remdesivir found effective as early treatment for COVID-19 … Social isolation linked to 27% increase in heart disease risk...
CMS memo: ‘Dramatic staff losses’ not happening due to vax requirements
By
James M. Berklan
Feb 02, 2022
Declaring once again that “Vaccine requirements work,” Centers for Medicare & Medicaid Services Administrator Chiquita Brooks-LaSure on Tuesday urged healthcare facility administrators to increase...
Governors ask for limited waivers on vaccine mandate
By
Danielle Brown
Feb 02, 2022
A pair of Republican governors have asked the Centers for Medicare & Medicaid Services for temporary relief from the healthcare worker COVID-19 vaccine mandate for rural providers and state-run facilities.
Operator accused of withholding employee raises worth $250,000
By
Danielle Brown
Feb 02, 2022
Connecticut lawmakers are pushing for a state investigation into a nursing home operator accused of not paying 4.5% salary increases after receiving state funding to do so.
Vaccines protect against omicron’s fast-spreading sister variant, BA.2, new data show
By
Alicia Lasek
Feb 01, 2022
COVID-19 vaccines will continue to protect the public against a spinoff omicron gene variant that’s making inroads across the United States, new data from the United Kingdom suggest.
U.S. gives green light to Moderna’s COVID-19 vaccine
By
Alicia Lasek
Feb 01, 2022
“Spikevax” is the second COVID-19 mRNA vaccine to receive full FDA approval, following Pfizer-BioNTech’s Comirnaty in September.
Diabetes deaths reach 100,000 second year in a row, sparking calls for federal action
By
Alicia Lasek
Feb 01, 2022
The news is cause for alarm, experts say. A congressional commission is calling for broad federal policy changes to tackle the swiftly growing problem.
Clinical briefs for Tuesday, Feb. 1
By
Alicia Lasek
Feb 01, 2022
FDA approves eye drug Vabysmo to treat ‘wet’ macular degeneration in older adults … Diet rich in flavonoid-rich foods boosts longevity in Parkinson’s disease … Allopurinol not linked to higher...